A method is described for generating a clinically significant volume of neural progenitor cells from whole bone marrow. A mass of bone marrow cells may be grown in a culture supplemented with fibroblast growth factor-2 (FGF-2) and epidermal growth factor (EGF). Further methods of the present invention are directed to utilizing the neural progenitor cells cultured in this fashion in the treatment of various neuropathological conditions, and in targeting delivery of cells transfected with a particular gene to diseased or damaged tissue.

 
Web www.patentalert.com

< Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow

> Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow

> Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow

~ 00504